Dr. Ebel's clinical and research interests lie at the intersection of the heart and the liver, specifically for Fontan associated liver disease and indications for combined heart-liver transplantation. She is the Director of the Alagille Syndrome Program at Stanford and supports a growing international referral program for patients with Alagille syndrome and their complex heart and liver needs.
https://www.stanfordchildrens.org/en/service/alagille-syndrome

Dr. Ebel is the Director of Policy in the Office of Child Health Equity at Stanford and is committed to eliminating health disparities for children with liver disease on both an institutional and national level. She works to galvanize pediatric subspecialists to engage in health policy and health equity work to assure equal care for all children. Her current work centers on equitable access to living donor liver transplantation.
https://tts.org/split-advocacy

Dr. Ebel is additionally the founder of the Stanford GI advocacy group:
https://med.stanford.edu/gastroenterology/DiversityEquityInclusion/PedsGIAdvocacy.html
And serves as the Program Director for the Transplant Hepatology fellowship.

Dr. Ebel most recently received early career investigator awards from the American Association for the Study of Liver Diseases (AASLD) and the International Pediatric Transplant Association (IPTA).

She can be found on social media: @NoelleEbelMD (Twitter)